Current Issue
Volumes and Issues
For Authors
Manuscript Guidelines
Review Process
Conflict of Interest
Copyright
About the Journal
Editorial Board
Aim and Scope
Policy and Ethical Guidelines
Promotion of the Journal
Print-Version Subscription
Publisher and Contact Information
Contact Information
Sign in as an AUTHOR/REVIEWER
ORIGINAL ARTICLE
WHEN SHOULD ONE LOOK FOR IVS1+1G>A SPLICE
MUTATION IN PATIENTS WITH NONSYNDROMIC
SENSORINEURAL HEARING LOSS?
1
Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Belarus
Publication date: 2014-06-30
Corresponding author
Olga Shubina-Oleinik
Olga Shubina-Oleinik, Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Belarus, e-mail: oleinik.olga@yahoo.co.uk
Olga Shubina-Oleinik, Institute of Genetics and Cytology, National Academy of Sciences of Belarus, Minsk, Belarus, e-mail: oleinik.olga@yahoo.co.uk
J Hear Sci 2014;4(2):24-29
KEYWORDS
ABSTRACT
Background:
The splice site nucleotide substitution IVS1+1G>A in the non-coding part of the GJB2 gene is one of the recessive pathogenic mutations causing nonsyndromic sensorineural hearing loss (NSHL). We present here the results of a study of IVS1+1G>A among Belarusian patients with NSHL as well as among Belarusian controls with normal hearing.
Material and Methods:
The PCR-RFLP method was used for genotyping. All tested patients were subdivided into three groups: those who carried only one mutant allele of GJB2 exon 2 (group A, 28 patients), those with no mutation of GJB2 exon 2 (group B, 150 patients), and patients with two mutations previously detected in the second exon of GJB2 or with one mutation and a large GJB6 deletion ∆D13S1830 (group C, 223 patients). Also 300 Belarusian people with normal hearing were screened for IVS1+1G>A.
Results:
We detected 7 patients with IVS1+1G>A mutation in the A group, which explained hearing loss in 25% of this deafness cohort. None of the B or C group patients carried the IVS1+1G>A mutation. We also did not find any IVS1+1G>A mutation carriers among the 300 Belarusian control people with normal hearing.
Conclusions:
IVS1+1G>A is the third-most frequent mutation (after 35delG and 312del14) among Belarusian patients with NSHL; its rate is 1.8% for the patient cohort we studied and the population frequency is below 0.33%. We propose to include the IVS1+1G>A mutation into a laboratory screening protocol for those patients with NSHL that carry one mutant allele of GJB2 exon 2.
The splice site nucleotide substitution IVS1+1G>A in the non-coding part of the GJB2 gene is one of the recessive pathogenic mutations causing nonsyndromic sensorineural hearing loss (NSHL). We present here the results of a study of IVS1+1G>A among Belarusian patients with NSHL as well as among Belarusian controls with normal hearing.
Material and Methods:
The PCR-RFLP method was used for genotyping. All tested patients were subdivided into three groups: those who carried only one mutant allele of GJB2 exon 2 (group A, 28 patients), those with no mutation of GJB2 exon 2 (group B, 150 patients), and patients with two mutations previously detected in the second exon of GJB2 or with one mutation and a large GJB6 deletion ∆D13S1830 (group C, 223 patients). Also 300 Belarusian people with normal hearing were screened for IVS1+1G>A.
Results:
We detected 7 patients with IVS1+1G>A mutation in the A group, which explained hearing loss in 25% of this deafness cohort. None of the B or C group patients carried the IVS1+1G>A mutation. We also did not find any IVS1+1G>A mutation carriers among the 300 Belarusian control people with normal hearing.
Conclusions:
IVS1+1G>A is the third-most frequent mutation (after 35delG and 312del14) among Belarusian patients with NSHL; its rate is 1.8% for the patient cohort we studied and the population frequency is below 0.33%. We propose to include the IVS1+1G>A mutation into a laboratory screening protocol for those patients with NSHL that carry one mutant allele of GJB2 exon 2.
FUNDING
The work was supported by a project grant from the Belarusian Republican Foundation for Fundamental Research
(BRFFR), project grant Б14Р-081.
REFERENCES (25)
1.
Kokotas H, Laer L, Grigoriadou M, Iliadou V, Economides J et al. Strong linkage disequilibrium for the frequent GJB2 35delG mutation in the Greek population. Am J Med Genet, 2008; 146A: 2879–84.
2.
Morton C, Nance W. Newborn hearing screening – a silent revolution. N Engl J Med, 2006; 354(20): 2151–64.
3.
Pollak A, Skórka A. M34T and V37I mutations in GJB2 associated hearing impairment: evidence for pathogenicity and reduced penetrance. Am J Med Genet, 2007; 143A(21): 2534–43.
5.
Snoeckx R, Camp G. Non-syndromic hearing loss: cracking the cochlear code. Nature, 2007; 45: 227–39.
6.
Wu C, Hung C, Lin S, Hsieh W, Tsao P et al. Newborn genetic screening for hearing impairment: a preliminary study at a tertiary center. PLoS ONE, 2012; 6(7): e22314.
7.
Rodriguez-Paris J, Schrijver I. The digenic hypothesis unraveled: the GJB6 del(GJB6-D13S1830) mutation causes allele-specific loss of GJB2 expression in cis. Biochem Biophys Res Commun, 2009; 389(2): 354–9.
8.
Lee J, White T. Connexin-26 mutations in deafness and skin disease. Expert Rev Mol Med, 2009; 11.e35.
9.
Zhao H, Kikuchi T, Ngezahayo A, White T. Gap junctions and cochlear homeostasis. J Membrane Biol, 2006; 209(2–3): 177–86.
10.
Tekin M, Xia X, Erdenetungalag R, Cengiz FB, White TW, et al. GJB2 mutations in Mongolia: complex alleles, low frequency, and reduced fitness of the deaf. Ann Hum Genet, 2010; 74(2): 155–64.
11.
Barashkov N, Dzhemileva L, Fedorova S. Autosomal recessive deafness 1A (DFNB1A) in Yakut population isolate in Eastern Siberia: extensive accumulation of the splice site mutation IVS1+1G>A in GJB2 gene as a result of founder effect. J Hum Genet, 2011; 56(9): 631–9.
12.
Hutchin T, Coy N, Conlon H, Telford E. Assessment of the genetic causes of recessive childhood non-syndromic deafness in the UK: implications for genetic testing. Clin Genet, 2005; 68(6): 506–12.
13.
Seeman P, Sakmaryova. High prevalence of the IVS1+1G to A/ GJB2 mutation among Czech hearing impaired patients with monoallelic mutation in the coding region of GJB2. Clin Genet, 2006; 69(5): 410–13.
14.
Denoyelle F, Marlin S, Marlin S, Weil D et al. Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet, 1999; 353(9161): 1298–303.
15.
Green G, Scott, McDonald J. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA, 1999; 281(23): 2211–16.
16.
Mani R, Ganapathy A, Jalvi R. Functional consequences of novel connexin 26 mutations associated with hereditary hearing loss. Eur J Hum Genet, 2009; 17(4): 502–9.
17.
Shahin H, Walsh T, Sobe T, Lynch E, King M et al. Genetics of congenital deafness in the Palestinian population: multiple connexin 26 alleles with shared origins in the Middle East. Hum Genet, 2002; 110(3): 284–89.
18.
Bliznetz EA, Galkina AV, Matyushchenko GN, Kisina AG, Markova TG, et al. Changes in the connexin 26 gene (GJB2) in Russian patients with hearing loss: results of long-term molecular diagnostics of hereditary nonsyndromic hearing loss. Genetika, 2012; 48(1): 101–12.
19.
Minárik G, Tretinárová D, Szemes T, Kádasi Ľ. Prevalence of DFNB1 mutations in Slovak patients with non-syndromic hearing loss. Int J Pediatric Otorhinolaryngol, 2012; 76(3): 400–3.
20.
Sansovic I, Knezevic J, Matijevic T, Balen S. Prevalence of the 35delG mutation in the GJB2 gene of patients with nonsyndromic hearing loss from Croatia. Genet Test, 2005; 9(4): 297–300.
21.
Santos RL, Aulchenko YS, Huygen PL, Donk KP, Wijs IJ. Hearing impairment in Dutch patients with connexin 26 (GJB2) and connexin 30 (GJB6) mutations. Int J Pediatric Otorhinolaryngol, 2005; 69(2): 165–74.
22.
Tóth T, Kupka S, Haack B. Coincidence of mutations in different connexin genes in Hungarian patients. Int J Mol Med, 2007; 20(3): 315–21.
23.
Danilenko N, Merkulava E, Siniauskaya M, Olejnik O. Spectrum of genetic changes in patients with non-syndromic hearing impairment and extremely high carrier frequency of 35delG GJB2 mutation in Belarus. PLoS ONE, 2012; 7(5): e36354.
24.
da Silva-Costa SM, Coeli FB, Lincoln-de-Carvalho CR, Marques-de-Faria AP, Kurc M et al. Screening for the GJB2 c.-3170 G>A (IVS1+1G>A) mutation in Brazilian deaf individuals using multiplex ligation-dependent probe amplification. Genet Test, 2009; 13: 701–4.
25.
Yuan Y, Yu F, Wang G, Huang S, Yu R et al. Prevalence of the GJB2 IVS1+1G >A mutation in Chinese hearing loss patients with monoallelic pathogenic mutation in the coding region of GJB2. J Transl Med, 2010; 8: 127.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
